Last updated on February 2017

A Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)


Brief description of study

A Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)

Detailed Study Description

The primary objective is to evaluate the efficacy and safety of phosphatidylserine (PS) on cognitive abilities in MCI

Clinical Study Identifier: TX9325

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Colleen Figueroa

University of South Florida - USF Health Psychiatry Center
Tampa, FL USA
  Connect »